Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

51.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.5K
What is Cancer?02:12

What is Cancer?

12.5K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.5K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.2K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.2K
Tumor Progression02:07

Tumor Progression

6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer Prevention02:59

Cancer Prevention

7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

497
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
497

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The family covenant: addressing disclosure, families, and family physicians.

The American journal of bioethics : AJOB·2003
Same author

The family covenant and genetic testing.

The American journal of bioethics : AJOB·2002
Same author

Risky business: evaluating oocyte donation.

The American journal of bioethics : AJOB·2002
Same author

Prognostic factors in clinical decision making: the future.

Cancer·2001
Same author

[Gynecologic tumors].

Minerva ginecologica·2001
Same author

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Archives of pathology & laboratory medicine·2000
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K

Breast cancer

J W Berg1, R V Hutter

  • 1Department of Pathology and Preventive Medicine, University of Colorado, Boulder.

Cancer
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Histologic type significantly impacts breast cancer survival rates, with in situ carcinomas showing nearly 100% survival. Invasive ductal carcinoma is most common, but other types like papillary and tubular adenocarcinomas have higher survival rates.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.4K
Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

80.3K

Related Experiment Videos

Last Updated: Nov 7, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.4K
Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

80.3K

Area of Science:

  • Oncology
  • Epidemiology
  • Cancer Research

Background:

  • Breast cancer is the leading cancer and second-highest cause of cancer death in US women.
  • Lung cancer causes more deaths annually than breast cancer.

Purpose of the Study:

  • To analyze the relative frequencies, incidence rates, and survival rates of various breast carcinoma histologic types.
  • To examine differences in breast cancer characteristics based on histologic classification.

Main Methods:

  • Analysis of 158,621 invasive and 10,639 in situ breast carcinoma cases from the National Cancer Institute's SEER program (1973-1987).
  • Examination of relative frequencies, incidence rates, and 5-year relative survival rates by histologic type.
  • Separate analysis of invasive breast carcinomas, in situ carcinomas, and sarcomas.

Main Results:

  • Infiltrating duct carcinoma (67.9%) had a 79% 5-year survival rate.
  • Lobular carcinoma (6.3%) had an 84% survival rate; medullary carcinoma (2.8%) had an 82% survival rate.
  • Carcinoma in situ demonstrated approximately 100% 5-year relative survival across all subtypes.

Conclusions:

  • Histologic type is a significant factor influencing breast cancer frequency, presentation, and patient survival.
  • The SEER program provides a robust, population-based dataset for breast cancer research in the US.
  • This data is crucial for understanding incidence and survival rates across different histologic types of breast cancer.